• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖微球用于在炎症关节中控制塞来昔布关节内递送的疗效。

Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints.

作者信息

Thakkar Hetal, Sharma R K, Mishra A K, Chuttani Krishna, Murthy R S R

机构信息

New Drug Delivery System Laboratory, Pharmacy Department, Donor's Plaza, Opp. To University main office, M. S. University of Baroda, Fatehgunj, Vadodara-390 002, India.

出版信息

J Pharm Pharmacol. 2004 Sep;56(9):1091-9. doi: 10.1211/0022357044166.

DOI:10.1211/0022357044166
PMID:15324477
Abstract

The use of polymeric carriers in formulations of therapeutic drug delivery systems has gained widespread application, due to their advantage of being biodegradable and biocompatible. In this study, we aimed to prepare celecoxib-loaded chitosan microspheres for intra-articular administration and to compare the retention of the celecoxib solution and chitosan microspheres in the joint cavity. The microspheres were characterized for entrapment efficiency, particle size and surface morphology by scanning electron microscopy. In-vitro drug release studies of microspheres revealed that the microspheres are able to control the release of celecoxib over a period of 96 h. Biodistribution studies of celecoxib and chitosan microspheres were performed by radiolabelling with( 99m)Tc and injecting intraarticularly in rats. The study indicated that following intra-articular administration the distribution of the drug to the organs, like liver and spleen, is very rapid compared with that of the microspheres. Compared with the drug solution, a 10-fold increase in the concentration of the drug in the joint was observed 24 h post intra-articular injection (P < 0.005) when drug was encapsulated in microspheres.

摘要

由于具有可生物降解和生物相容性的优点,聚合物载体在治疗性药物递送系统制剂中的应用已得到广泛应用。在本研究中,我们旨在制备用于关节内给药的载塞来昔布壳聚糖微球,并比较塞来昔布溶液和壳聚糖微球在关节腔内的滞留情况。通过扫描电子显微镜对微球的包封率、粒径和表面形态进行了表征。微球的体外药物释放研究表明,微球能够在96小时内控制塞来昔布的释放。通过用(99m)Tc进行放射性标记并在大鼠关节内注射,对塞来昔布和壳聚糖微球进行了生物分布研究。研究表明,关节内给药后,与微球相比,药物向肝脏和脾脏等器官的分布非常迅速。与药物溶液相比,当药物封装在微球中时,关节内注射24小时后关节内药物浓度增加了10倍(P < 0.005)。

相似文献

1
Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints.壳聚糖微球用于在炎症关节中控制塞来昔布关节内递送的疗效。
J Pharm Pharmacol. 2004 Sep;56(9):1091-9. doi: 10.1211/0022357044166.
2
Albumin microspheres as carriers for the antiarthritic drug celecoxib.白蛋白微球作为抗关节炎药物塞来昔布的载体。
AAPS PharmSciTech. 2005 Sep 20;6(1):E65-73. doi: 10.1208/pt060112.
3
Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration.关节腔内给药后载塞来昔布固体脂质纳米粒的保留率提高。
Drugs R D. 2007;8(5):275-85. doi: 10.2165/00126839-200708050-00002.
4
Celecoxib incorporated chitosan microspheres: in vitro and in vivo evaluation.塞来昔布包载壳聚糖微球:体外及体内评价
J Drug Target. 2004;12(9-10):549-57. doi: 10.1080/10611860400010630.
5
Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits.用紫杉醇微球制剂进行关节炎的关节内治疗:兔体内生物相容性和疗效测定
Inflamm Res. 2004 Aug;53(8):363-72. doi: 10.1007/s00011-004-1273-1. Epub 2004 Aug 10.
6
Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration.载洛昔康 PLGA 微球经关节腔内给药后的靶向效率增强。
Drug Deliv. 2011 Sep-Oct;18(7):536-44. doi: 10.3109/10717544.2011.596584. Epub 2011 Aug 4.
7
Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.载塞来昔布结肠靶向性 Eudragit® S100 包衣聚己内酯微球的制备、表征及在大鼠体内的评价。
Drug Deliv. 2011 Sep-Oct;18(7):523-35. doi: 10.3109/10717544.2011.595841. Epub 2011 Jul 28.
8
Intra-articular lornoxicam loaded PLGA microspheres: enhanced therapeutic efficiency and decreased systemic toxicity in the treatment of osteoarthritis.关节内负载洛索洛芬的 PLGA 微球:在治疗骨关节炎方面提高治疗效果和降低全身毒性。
Drug Deliv. 2012 Jun-Jul;19(5):255-63. doi: 10.3109/10717544.2012.700962. Epub 2012 Jul 9.
9
Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex.基于设计的质量控制方法用于开发壳聚糖-海藻酸钙微球用于塞来昔布-羟丙基-β-环糊精-PVP 复合物的结肠递药。
Eur J Pharm Biopharm. 2012 Jan;80(1):67-75. doi: 10.1016/j.ejpb.2011.08.002. Epub 2011 Aug 16.
10
Development of brucine-loaded microsphere/thermally responsive hydrogel combination system for intra-articular administration.载马钱子碱微球/温敏水凝胶联合系统的研制及其关节腔内给药
J Control Release. 2012 Sep 28;162(3):628-35. doi: 10.1016/j.jconrel.2012.07.037. Epub 2012 Aug 7.

引用本文的文献

1
A combination of chitosan nanoparticles loaded with celecoxib and kartogenin has anti-inflammatory and chondroprotective effects: Results from an model of osteoarthritis.负载塞来昔布和软骨生成素的壳聚糖纳米颗粒组合具有抗炎和软骨保护作用:骨关节炎模型的结果
Heliyon. 2024 May 10;10(10):e31058. doi: 10.1016/j.heliyon.2024.e31058. eCollection 2024 May 30.
2
PPARα-ACOT12 axis is responsible for maintaining cartilage homeostasis through modulating de novo lipogenesis.过氧化物酶体增殖物激活受体α-酰基辅酶 A 转移酶 12 轴通过调节从头脂肪生成来维持软骨内稳态。
Nat Commun. 2022 Jan 5;13(1):3. doi: 10.1038/s41467-021-27738-y.
3
Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory Agents.
载药超分子丝状水凝胶作为抗炎剂
Theranostics. 2017 May 12;7(7):2003-2014. doi: 10.7150/thno.19404. eCollection 2017.
4
Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint.阳离子聚乳酸-羟基乙酸共聚物/聚丙烯酸树脂RL纳米颗粒用于增加膝关节腔内注射后在滑膜腔中的滞留时间。
Int J Nanomedicine. 2015 Aug 24;10:5263-71. doi: 10.2147/IJN.S88363. eCollection 2015.
5
Nanoparticles for improved local retention after intra-articular injection into the knee joint.关节内注射膝关节后改善局部滞留的纳米颗粒。
Pharm Res. 2013 Jan;30(1):257-68. doi: 10.1007/s11095-012-0870-x. Epub 2012 Sep 21.
6
Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.药物剂型材料:分子药剂学与控释药物递送方面
Int J Mol Sci. 2010 Sep 15;11(9):3298-322. doi: 10.3390/ijms11093298.
7
Release and activity of anti-TNFalpha therapeutics from injectable chitosan preparations for local drug delivery.用于局部给药的可注射壳聚糖制剂中抗TNFα治疗药物的释放与活性
J Biomed Mater Res B Appl Biomater. 2009 Jul;90(1):319-26. doi: 10.1002/jbm.b.31289.
8
Emerging intra-articular drug delivery systems for the temporomandibular joint.用于颞下颌关节的新兴关节内药物递送系统。
Methods. 2009 Feb;47(2):134-40. doi: 10.1016/j.ymeth.2008.09.001. Epub 2008 Oct 1.
9
Recent advances in the pharmacological management of pain.疼痛药物治疗的最新进展。
Drugs. 2007;67(15):2121-33. doi: 10.2165/00003495-200767150-00002.
10
New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly.用于环氧化酶-2抑制剂靶向递送的新剂型:聚焦于在老年人中的应用。
Drugs Aging. 2007;24(6):441-51. doi: 10.2165/00002512-200724060-00001.